...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH(3))CL(2) where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-alpha)pyridine.
【24h】

Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH(3))CL(2) where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-alpha)pyridine.

机译:合成和表征四种反式-平面-PtL(NH(3))CL(2)的反式-平面胺铂(II)配合物的研究,其中L = 2-羟基吡啶,3-羟基吡啶,咪唑和咪唑(1,2) -α)吡啶。

获取原文
获取原文并翻译 | 示例
           

摘要

Four trans-planaramineplatinum(II) complexes code named YH9, YH10, YH11 and YH12, each of the form trans-PtL(NH(3))Cl(2) where L = 2-hydroxypyridine and 3-hydroxypyridine, imidazole, and imidazo(1,2-alpha)pyridine for YH9, YH10, YH11 and YH12, respectively. All of the compounds have significant anticancer activity against human cancer cell lines. YH12 is found to be significantly more active than cisplatin against cisplatin-resistant ovary cell line A2780(cisR).
机译:四个反式-平面胺铂(II)配合物,代码分别为YH9,YH10,YH11和YH12,形式分别为反式PtL(NH(3))Cl(2),其中L = 2-羟基吡啶和3-羟基吡啶,咪唑和咪唑YH9,YH10,YH11和YH12分别为(1,2-α)吡啶。所有这些化合物对人癌细胞具有显着的抗癌活性。发现YH12对顺铂耐药卵巢细胞系A2780(cisR)的活性明显高于顺铂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号